Robin Swartz, Chief Operating Officer at Voyager Therapeutics, Inc. (VYGR), sold 30,746 shares at $8.20 ($252K) on 2023-03-15, disclosed to the SEC on 2023-03-17.
Open-market sale of $252k VYGR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.20 | 15,373 | $126K | 50.0% |
| 2 | $8.20 | 15,373 | $126K | 50.0% |
| Total | $8.20 avg | 30,746 | $252K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-11 | $18K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $17K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $31K | — | Filing → |